查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
糖尿病足溃疡治疗市场 - 全球行业规模、份额、趋势、机会和预测，2018-2028 年：按治疗、按溃疡类型、按最终用户、按地区细分、竞争
市场调查报告书
商品编码
1255237

糖尿病足溃疡治疗市场 - 全球行业规模、份额、趋势、机会和预测，2018-2028 年：按治疗、按溃疡类型、按最终用户、按地区细分、竞争

Diabetic Foot Ulcer Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Treatment, By Ulcer Type, By End User, By Region, and Competition
出版日期: | 出版商: TechSci Research | 英文 119 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球糖尿病足溃疡治疗市场预计在预测期内将出现显着增长。

除了不健康的饮食习惯外，越来越多的人过着久坐不动的生活方式。 此外，对无痛和低成本治疗的需求不断增加，加上审美观的提高，大大增加了世界各个地区对糖尿病足溃疡治疗的需求。 此外，世界各地日益老龄化的人口容易患足部溃疡等各种类型的溃疡病，这将进一步增加对各种牙齿轮廓的需求，推动市场增长到 2028 年。预计。 此外，由于全球不健康的生活方式导致肥胖症日益流行，预计在预测期内将进一步支持糖尿病足溃疡治疗市场。 此外，合适的医疗器械和药品的使用率增加预计将增加对糖尿病足溃疡治疗的需求，这将推动市场的增长。 根据美国疾病控制和预防中心 (CDC) 的数据，美国 600 万 18 岁及以上的人患有糖尿病前期，2640 万 65 岁及以上的人 (48.8%) 患有糖尿病前期。

糖尿病足溃疡患病率上升

快速增长的老年人口更容易患上各种类型的溃疡等慢性病。 这一因素有望在未来几年推动糖尿病足溃疡治疗市场。 由于外周血管疾病、葡萄糖相关疾病和其他慢性病的患病率增加，医院获得性压力性溃疡的风险增加，预计将在预测期内推动该行业的发展。 发达国家和发展中国家肥胖和外周动脉疾病的不断增加降低了运动能力并增加了患慢性溃疡的风险。 同样，由于垃圾食品和饮酒而导致不健康的生活方式会导致人们患上肥胖症和糖尿病，进而造成更多的溃疡，从而推动预测期内市场的增长。 2019 年，3730 万美国人（占人口的 11.3%）患有糖尿病。 约有 190 万美国人患有 1 型糖尿病，其中包括约 244,000 名儿童和青少年。 由于发展中地区老龄化社会中 1 型糖尿病和成熟期糖尿病发病率的增加，糖尿病足溃疡变得越来越普遍，这将进一步推动预测期内的市场增长。

技术进步

政府机构在研发领域不断增加的投资和举措是推动全球市场发展的关键因素。 糖尿病足溃疡新疗法的不断发展和进步预计将在预测期内产生显着增长。 例如，2019 年 7 月，全球再生医学公司 AVITA Medical 宣布其用于治疗糖尿病足溃疡的 RECELL 自体细胞采集装置的开放标籤可行性研究取得积极成果。 随着医院设施的可用性，越来越多的人选择治疗糖尿病足溃疡。 高级伤口护理正在蓬勃发展，并将进一步吸引新进入者进入该市场。 新生物製剂的开发、技术创新以及皮肤移植的研发有望在未来几年进一步推动市场增长。

近期发展

  • 2019年1月，UPM在欧洲市场推出了一款全新的先进伤口护理产品FibDex，这是一种由木基纳米原纤维纤维素製成的伤口敷料，已获得监管机构批准。已获得 CE 标誌。

可定制产品

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第 5 章糖尿病足溃疡的全球市场展望

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗剂（伤口敷料、生物製剂、治疗设备、抗生素等）
    • 按溃疡类型（神经性溃疡、缺血性溃疡、神经源性缺血性溃疡）
    • 按最终用户（医院/诊所、门诊诊所、其他）
    • 按地区
    • 按公司分类（2022 年）
  • 市场地图
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按地区

第 6 章北美糖尿病足溃疡治疗市场展望

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲糖尿病足溃疡治疗市场前景

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 8 章亚太地区糖尿病足溃疡治疗市场展望

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章南美糖尿病足溃疡治疗市场展望

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按国家
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第10章中东和非洲糖尿病足溃疡药物市场展望

  • 市场规模和预测
    • 按数量
  • 市场份额和预测
    • 按治疗方法
    • 按溃疡类型
    • 最终用户
    • 按国家
  • MEA：国家分析
    • 南非糖尿病足溃疡药物
    • 沙特阿拉伯糖尿病足溃疡药物
    • 阿联酋糖尿病足溃疡药物
    • Turkiye 糖尿病足溃疡治疗
    • 埃及糖尿病足溃疡药物

第 11 章市场动态

  • 司机
  • 任务

第12章市场趋势与发展

  • 近期趋势
  • M&A（併购）
  • 产品发布

第13章竞争格局

  • 3M Company
  • Medtronic Plc
  • ConvaTec, Inc.
  • Coloplast Corporation
  • Smith & Nephew Plc
  • B Braun Melsungen AG
  • Medline Industries, Inc.
  • Organogenesis, Inc.
  • Molnlycke Health Care AB
  • Acelity L.P., Inc.

第 14 章战略建议

简介目录
Product Code: 14342

The global diabetic foot ulcer treatment market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasingly leading sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless Treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe, which is susceptible to different kinds of ulcer diseases like foot ulcers, is further expected to increase the demand for different dental contouring procedures, thereby fuelling the market growth through 2028. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period. Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States, and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

Growing Prevalence of Diabetic Foot Ulcer

The rapidly increasing geriatric population is highly susceptible to chronic diseases such as different types of ulcers. This factor is expected to propel the diabetic foot ulcer treatment market in the next few years. An increase in the prevalence of peripheral vascular as well as sugar-related diseases and other chronic diseases leading to a rising risk of hospital-acquired pressure ulcers is expected to drive the segment during the forecast period. Constantly increasing obesity and peripheral artery diseases among developed and developing countries lead to decreased mobility and increased risk of acquiring chronic ulcers. Similarly, leading unhealthy lifestyles due to consuming junk food and alcohol, people are affected with obesity and diabetes, which will further create ulcers and enhance the growth of the market during the forecast period. In 2019, 37.3 million Americans, or 11.3% of the population, had diabetes. Nearly 1.9 million Americans have type 1 diabetes, including about 244,000 children and adolescents. Diabetic foot ulcers are more common because of the growing incidence in both types of I and maturity-onset diabetes among the aging population in the developing region, which will further propel the growth of the market during the forecast period.

Technological Advancement

Increasing investment and initiative by a government organization for research and development sectors is a major factor driving the market across the globe. An increase in the development of new treatments and advancement in diabetic foot ulcers is expected to create significant growth in the forecast period. For instance, in July 2019, AVITA Medical, g global regenerative medicine company, announced favorable results from an open-label feasibility study of the RECELL Autologous Cell Harvesting Device for the Treatment of Diabetic Foot Ulcers. Increasingly better hospital facility boosts the number of people opting for diabetic foot ulcer treatment. Advanced wound care is rapidly growing, which will further attract new players to invest in this market. Growing development in new biologic products, innovation, and research in skin grafts will further drive the growth of the market over the years.

Market Segmentation

The global diabetic foot ulcer treatment market can be segmented by Treatment, ulcer treatment, End User, and by region. Based on Treatment, the market can be segmented into Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, and Others. Based on ulcer treatment, the market can be differentiated into Neuropathic Ulcers, Ischemic Ulcers, and Neuroischemic Ulcers. Based on End Users, the market can be grouped into Hospitals & Clinics, Ambulatory Care Centers, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global diabetic foot ulcer treatment market.

Recent Developments

  • In January 2019, UPM launched a new advanced wound care product in the European market, and FibDex is the product for wound dressing, created from wood-based nano fibrillar cellulose, to receive regulatory approval and to be awarded a CE mark.

Market Players

3M Company, Medtronic Plc, ConvaTec, Inc., Coloplast Corporation, Smith & Nephew Plc, B Braun Melsungen AG, Medline Industries, Inc., Organogenesis, Inc., Molnlycke Health Care AB, Acelity L.P., Inc. are some of the leading players operating in the Global Diabetic Foot Ulcer Treatment Market.

Report Scope

In this report, global diabetic foot ulcer treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Diabetic Foot Ulcer Treatment Market, By Treatment:

  • Wound Care Dressings
  • Biologics
  • Therapy Devices
  • Antibiotic Medications
  • Others

Diabetic Foot Ulcer Treatment Market, By Ulcer Treatment:

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuroischemic Ulcers

Diabetic Foot Ulcer Treatment Market, By End User:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Diabetic Foot Ulcer Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Diabetic Foot Ulcer Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Foot Ulcer Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
    • 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Treatment
    • 5.3.2. By Ulcer Type
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Diabetic Foot Ulcer Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Treatment
    • 6.2.2. By Ulcer Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Treatment
        • 6.3.1.2.2. By Ulcer Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Treatment
        • 6.3.2.2.2. By Ulcer Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Treatment
        • 6.3.3.2.2. By Ulcer Type
        • 6.3.3.2.3. By End User

7. Europe Diabetic Foot Ulcer Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Treatment
    • 7.2.2. By Ulcer Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Treatment
        • 7.3.1.2.2. By Ulcer Type
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Treatment
        • 7.3.2.2.2. By Ulcer Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Treatment
        • 7.3.3.2.2. By Ulcer Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Treatment
        • 7.3.4.2.2. By Ulcer Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Treatment
        • 7.3.5.2.2. By Ulcer Type
        • 7.3.5.2.3. By End User

8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Treatment
    • 8.2.2. By Ulcer Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Treatment
        • 8.3.1.2.2. By Ulcer Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Treatment
        • 8.3.2.2.2. By Ulcer Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Treatment
        • 8.3.3.2.2. By Ulcer Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Treatment
        • 8.3.4.2.2. By Ulcer Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Treatment
        • 8.3.5.2.2. By Ulcer Type
        • 8.3.5.2.3. By End User

9. South America Diabetic Foot Ulcer Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Treatment
    • 9.2.2. By Ulcer Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Treatment
        • 9.3.1.2.2. By Ulcer Type
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Treatment
        • 9.3.2.2.2. By Ulcer Type
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Treatment
        • 9.3.3.2.2. By Ulcer Type
        • 9.3.3.2.3. By End User

10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Treatment
    • 10.2.2. By Ulcer Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Treatment
        • 10.3.1.2.2. By Ulcer Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Treatment
        • 10.3.2.2.2. By Ulcer Type
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Treatment
        • 10.3.3.2.2. By Ulcer Type
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Treatment
        • 10.3.4.2.2. By Ulcer Type
        • 10.3.4.2.3. By End User
    • 10.3.5. Egypt Diabetic Foot Ulcer Treatment Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Treatment
        • 10.3.5.2.2. By Ulcer Type
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. 3M Company
    • 13.6.2. Medtronic Plc
    • 13.6.3. ConvaTec, Inc.
    • 13.6.4. Coloplast Corporation
    • 13.6.5. Smith & Nephew Plc
    • 13.6.6. B Braun Melsungen AG
    • 13.6.7. Medline Industries, Inc.
    • 13.6.8. Organogenesis, Inc.
    • 13.6.9. Molnlycke Health Care AB
    • 13.6.10. Acelity L.P., Inc.

14. Strategic Recommendations